Ernexa Therapeutics, Inc. (ERNA)
1.36
-0.27
(-16.56%)
USD |
NASDAQ |
Nov 20, 16:00
1.41
+0.05
(+3.68%)
After-Hours: 20:00
Ernexa Therapeutics Market Cap : 2.237M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 2.237M |
| November 19, 2026 | 2.681M |
| November 18, 2026 | 2.665M |
| November 17, 2026 | 2.681M |
| November 16, 2026 | 2.78M |
| November 13, 2026 | 2.764M |
| November 12, 2026 | 2.945M |
| November 11, 2026 | 3.175M |
| November 10, 2026 | 3.306M |
| November 09, 2026 | 3.372M |
| November 06, 2026 | 3.093M |
| November 05, 2026 | 3.010M |
| November 04, 2026 | 3.274M |
| November 03, 2026 | 3.323M |
| November 02, 2026 | 2.282M |
| October 30, 2026 | 2.305M |
| October 29, 2026 | 2.469M |
| October 28, 2026 | 2.317M |
| October 27, 2026 | 2.332M |
| October 26, 2026 | 2.268M |
| October 23, 2026 | 2.416M |
| October 22, 2026 | 2.428M |
| October 21, 2026 | 2.469M |
| October 20, 2026 | 2.621M |
| October 19, 2026 | 2.317M |
| Date | Value |
|---|---|
| October 16, 2026 | 2.445M |
| October 15, 2026 | 2.539M |
| October 14, 2026 | 2.469M |
| October 13, 2026 | 2.586M |
| October 12, 2026 | 2.586M |
| October 09, 2026 | 2.808M |
| October 08, 2026 | 2.913M |
| October 07, 2026 | 2.796M |
| October 06, 2026 | 2.615M |
| October 05, 2026 | 3.159M |
| October 02, 2026 | 3.463M |
| October 01, 2026 | 3.463M |
| September 30, 2026 | 3.744M |
| September 29, 2026 | 3.697M |
| September 28, 2026 | 4.060M |
| September 25, 2026 | 4.031M |
| September 24, 2026 | 4.235M |
| September 23, 2026 | 4.270M |
| September 22, 2026 | 4.446M |
| September 21, 2026 | 4.633M |
| September 18, 2026 | 4.481M |
| September 17, 2026 | 4.399M |
| September 16, 2026 | 4.575M |
| September 15, 2026 | 4.774M |
| September 14, 2026 | 4.996M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cerenome, Inc. | 4.965M |
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
Market Cap Related Metrics
| Price to Book Value | 0.5143 |
| Price | 1.36 |
| Earnings Yield | -1.25K% |